| INTRODUCTION
Despite increased capabilities for the detection and surveillance of influenza viruses in many parts of the world, 1 whole-genomic data on the viruses from sub-Saharan Africa remain limited. Yet wholegenome sequencing provides the needed evidence for scientifically sound public health interventions including vaccine development.
Due to constant viral antigenic evolution, it is important to continually examine the evolutionary changes in the strains for appropriate vaccine selection each year. 
| ETHICALAPPROVAL

| RESULTS
Influenza A(H1N1)pdm09 was the second most predominant strain during the period (36%; 73/199 influenza isolates) which by December 2009 had completely replaced the seasonal influenza H1N1 (Fig 1) .
Virus isolates did not show significant antigenic differences from the vaccine strain A/California/07/2009 (Table 1) but those isolated subsequently had additional differences from the A/California/07/2009 strain ( Table 2 ). While there were no age-or gender-related differences in the isolates, it was noted that the strains isolated from Jinja Hospital could be differentiated from the strains from the other hospital sites by an amino acid Y366F substitution in the HA gene. Most of the 2010 influenza A(H1N1)pdm09 strains had the amino acid substitutions V36I, S145P, I303V, and I341V. The late 2010 and the 2011 influenza A(H1N1)pdm09 strains were further defined by amino acid substitutions A151, S200P, and E516K, and there were additional amino acid substitutions in the 2011 isolates as shown in Table 2 .
Phylogenetic analysis of NA also revealed a low genetic variation (genetic distance 0.1%-1.6%) at the nucleotide level (Fig. 3 The phylogenetic tree of PB2 (Fig. 4) and other gene segments 
| DISCUSSION
Genome analysis helps understand the molecular evolution of viruses and other genetic factors unique to isolates that might help inform the formulation of vaccines for specific regions. While the influenza A(H1N1)pdm09 strains isolated in this study had specific amino acids that defined them, they were generally similar to the reference strains, with no significant antigenic variation from the vaccine strain A/California/07/2009. 8 Consistent with findings from previous reports, 9-12 the isolates from our study showed low genetic diversity.
Despite this, the viruses isolated in different seasons clustered closely in the phylogenetic trees and could fairly be separated from each other. The influenza A(H1N1)pdm09 strains completely replaced the seasonal H1N1 strains shortly after the 2009 pandemic, and these strains have not been isolated since that time, a phenomenon reported in other regions of the world.
13
The limited information on whole-genome sequences from influenza virus strains from sub-Saharan Africa has constrained the region's contribution toward generating the information needed to develop new vaccines, therapies, and diagnostics for influenza. There are reported mutations in the influenza A(H1N1)pdm09
strains that can lead to increased fitness. 14 However, on the basis of SF analysis, the isolates in our study did not carry amino acid substitutions that are associated with efficient transmission or fitness, although biological experiments would be needed to further confirm this observation. Genetic changes in influenza viruses often arise as a result of several years of re-assortment among different subtypes of viruses. 15 Most of the isolates in our study shared high similarity with contemporary reference strains from other regions, which indicates that the Uganda viruses could be because of the introduction of new viruses into Uganda from the rest of the world rather than independent evolution of variants within Uganda. 
| CONCLUSION
The sequence feature (SF) variant type analysis of the genomes of our isolates did not predict key mutations associated with functional, epitope, and structural features that are related to increased fitness and antigenic variations. Nevertheless, accumulated amino acid substitutions were identified and with the ability of these viruses to undergo rapid mutations, it is critical to maintain continuous surveillance to identify any important changes that might be associated with increase viral fitness and transmissibility.
